Karan Takhar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karan Takhar
Karan Takhar was last confirmed as Board Member at Aura Biosciences, Inc. (AURA) in a filing dated April 25, 2023. Earlier roles on record: Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL) until December 15, 2025. Zentalis Pharmaceuticals, Inc. reported in an 8-K filed December 15, 2025 that Karan Takhar resigned as member of the Board of Directors, effective December 15, 2025.
“On December 15, 2025, Karan Takhar, who serves as Senior Managing Director and head of Life Sciences investing at Matrix Capital Management Company, L.P., resigned from his position as a member of the Board of Directors of Zentalis Pharmaceuticals, Inc. (the "Company") and from all of the committees on which he served, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2023-04-25
Last confirmed by a filing; no departure on record
-
2017-01-01–2025-12-15
-
2017-01-01–2025-12-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.